tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

XFOR Stock Latest News

X4 Pharmaceuticals presents data from its Phase 2 trial of mavorixafor
The FlyX4 Pharmaceuticals presents data from its Phase 2 trial of mavorixafor
7d ago
XFOR
X4 Pharmaceuticals Elects New Director at Annual Meeting
PremiumCompany Announcements
X4 Pharmaceuticals Elects New Director at Annual Meeting
12d ago
8K
XFOR
X4 Pharmaceuticals granted Fast Track designation for mavorixafor by FDA
PremiumThe Fly
X4 Pharmaceuticals granted Fast Track designation for mavorixafor by FDA
13d ago
XFOR
X4 Pharmaceuticals price target raised to $7 from $1.50 at H.C. Wainwright
PremiumThe Fly
X4 Pharmaceuticals price target raised to $7 from $1.50 at H.C. Wainwright
2M ago
XFOR
X4 Pharmaceuticals Reports Positive Q1 2025 Results
PremiumCompany Announcements
X4 Pharmaceuticals Reports Positive Q1 2025 Results
2M ago
XFOR
X4 Pharmaceuticals’ Earnings Call: Progress Amid Challenges
PremiumCompany AnnouncementsX4 Pharmaceuticals’ Earnings Call: Progress Amid Challenges
2M ago
XFOR
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
NVS
ABEO
X4 Pharmaceuticals Reports Q1 2025 Financial Results
Premium
Company Announcements
X4 Pharmaceuticals Reports Q1 2025 Financial Results
2M ago
8K
XFOR
X4 Pharmaceuticals reports Q1 EPS 4c vs. ($7.77) last year
PremiumThe Fly
X4 Pharmaceuticals reports Q1 EPS 4c vs. ($7.77) last year
2M ago
XFOR
X4 Pharmaceuticals management to meet with Cantor Fitzgerald
PremiumThe Fly
X4 Pharmaceuticals management to meet with Cantor Fitzgerald
2M ago
XFOR
X4 Pharmaceuticals trading halted, news pending
PremiumThe Fly
X4 Pharmaceuticals trading halted, news pending
2M ago
XFOR
X4 Pharmaceuticals announces 1-for-30 reverse stock split
PremiumThe Fly
X4 Pharmaceuticals announces 1-for-30 reverse stock split
2M ago
XFOR
X4 Pharmaceuticals’ Earnings Call Highlights Growth and Challenges
PremiumCompany AnnouncementsX4 Pharmaceuticals’ Earnings Call Highlights Growth and Challenges
3M ago
XFOR
X4 Pharmaceuticals: Strong Buy Rating Backed by Promising Drug Commercialization and Robust Financial Health
Premium
Ratings
X4 Pharmaceuticals: Strong Buy Rating Backed by Promising Drug Commercialization and Robust Financial Health
3M ago
XFOR
X4 Pharmaceuticals Reports 2024 Financial Results
Premium
Company Announcements
X4 Pharmaceuticals Reports 2024 Financial Results
3M ago
XFOR
X4 Pharmaceuticals reports Q4 EPS (20c) vs. (10c) last year
PremiumThe Fly
X4 Pharmaceuticals reports Q4 EPS (20c) vs. (10c) last year
3M ago
XFOR
X4 Pharmaceuticals price target lowered to $3 from $4 at Stifel
PremiumThe Fly
X4 Pharmaceuticals price target lowered to $3 from $4 at Stifel
3M ago
XFOR
Options Volatility and Implied Earnings Moves Today, March 25, 2025
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, March 25, 2025
3M ago
GME
MKC
Options Volatility and Implied Earnings Moves This Week, March 24 – March 27, 2025
PremiumMarket News
Options Volatility and Implied Earnings Moves This Week, March 24 – March 27, 2025
3M ago
CAN
DDD
X4 Pharmaceuticals (XFOR) Q4 Earnings Cheat Sheet
PremiumPre-EarningsX4 Pharmaceuticals (XFOR) Q4 Earnings Cheat Sheet
3M ago
XFOR
X4 and taiba rare announce distribution agreement for Xolremdi
Premium
The Fly
X4 and taiba rare announce distribution agreement for Xolremdi
4M ago
XFOR
Strategic Restructuring and Market Opportunities Drive Buy Rating for X4 Pharmaceuticals
Premium
Ratings
Strategic Restructuring and Market Opportunities Drive Buy Rating for X4 Pharmaceuticals
5M ago
XFOR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >